IJDVL Home  

[View FULLTEXT]   
Year : 1999  |  Volume : 65  |  Issue : 3  |  Page : 122-123

Short term treatment of pityrosporum folliculitis with itraconazole

D Prasad1, R Saini2, KS Negi3 

Correspondence Address:
D Prasad

We compared the efficacy and safely of short-term itraconazole with that of placebo in 26 patients of pityrosporum folliculitis. Twenty-six patients of mycologically proven pityrosporum folliculitis entered a double-blind placebo-controlled trial. Patients were randomly assigned to 7 days of treatment with either itraconazole, 200 mg once daily, or placebo. A global clinical assessment and mycological examination (KOH and smear examination) were performed at baseline and at 4 weeks after treatment. In this study, itraconazole in a dose of 200 mg for 7 days produced a distinct and statistically significant improvement over placebo (p<0.01). 84.6% of itraconazole treated patients were considered to be healed or markedly improved at the study«SQ»s end point compared with 8.3% of placebo treated group (p<0.01). Eighty-four percent of patients receiving active treatment showed negative mycological examination as compared to 8.3% of placebo-treated group (p<0.01). Short-term treatment with itraconazole is effective and well tolerated in the management of pityrosporum folliculitis.

How to cite this article:
Prasad D, Saini R, Negi K S. Short term treatment of pityrosporum folliculitis with itraconazole.Indian J Dermatol Venereol Leprol 1999;65:122-123

How to cite this URL:
Prasad D, Saini R, Negi K S. Short term treatment of pityrosporum folliculitis with itraconazole. Indian J Dermatol Venereol Leprol [serial online] 1999 [cited 2019 Nov 16 ];65:122-123
Available from: http://www.ijdvl.com/article.asp?issn=0378-6323;year=1999;volume=65;issue=3;spage=122;epage=123;aulast=Prasad;type=0


Saturday, November 16, 2019
 Site Map | Home | Contact Us | Feedback | Copyright and disclaimer